Sectra AB Share Price
Stocks
SECT B
SE0022419784
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
17:00:00 14/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 307.60 SEK | -0.65% |
|
+5.27% | +22.55% |
| 10-12 | Sectra Signs Service Contract With British Pathology Company Diagnexia | MT |
| 10-12 | Sectra AB Signs Agreement With Diagnexia To Speed Up Pathology Reporting For The NHS | CI |
| Market Cap | 59.65B 5.92B 5.33B 4.97B 4.5B 8.46B 564B 8.51B 23.29B 293B 22.24B 21.76B 941B | P/E 2027 * |
79.9x | P/E 2028 * | 69.1x |
|---|---|---|---|---|---|
| Enterprise Value | 57.99B 5.76B 5.18B 4.83B 4.38B 8.22B 548B 8.27B 22.64B 284B 21.62B 21.15B 915B | EV / Sales 2027 * |
13.9x | EV / Sales 2028 * | 11.9x |
| Free-Float |
65.73% | Yield 2027 * |
0.64% | Yield 2028 * | 0.71% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| SECT B | Delayed | |
CBOE
| SECTBs | Real-time | |
Tradegate
| 61L0 | Real-time | |
Boerse Muenchen
| 61L0 | Real-time | |
CBOE
| 0A0L | Real-time | |
Deutsche Boerse AG
| 61L0 | Delayed | |
Borsa Italiana
| 1SECT | End-of-day quote | |
Börse Stuttgart
| 61L0 | Delayed |
Last Transcript: Sectra AB
| 1 day | -0.65% | ||
| 1 week | +5.27% | ||
| Current month | +5.27% | ||
| 1 month | +4.70% | ||
| 3 months | +7.93% | ||
| 6 months | +23.73% | ||
| Current year | +22.55% |
| 1 week | 287.8 | 317.6 | |
| 1 month | 275.8 | 317.6 | |
| Current year | 173.3 | 317.6 | |
| 1 year | 173.3 | 317.6 | |
| 3 years | 117.1 | 377.4 | |
| 5 years | 111.4 | 377.4 | |
| 10 years | 24.8 | 377.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 69 | 31/10/2012 | |
| Director of Finance/CFO | 50 | 19/03/2022 | |
Per Andersnäs
CTO | Chief Tech/Sci/R&D Officer | 64 | 31/12/1996 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 05/09/2018 | |
| Director/Board Member | 69 | 31/12/1984 | |
Anders Persson
BRD | Director/Board Member | 73 | 31/12/2003 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/07/26 | Sell | -13,351 | 0.0073% | |||
| 06/07/26 | Sell | -3,649 | 0.0020% | |||
| 29/04/25 | Buy | Director | 736 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.65% | +5.27% | +2.67% | +148.67% | 5.98B | ||
| +1.93% | +2.20% | +28.67% | +38.50% | 245B | ||
| +1.03% | +2.96% | +9.12% | +6.89% | 157B | ||
| -1.17% | +0.77% | -4.28% | +52.36% | 149B | ||
| -1.74% | +2.30% | -55.80% | -15.10% | 62.77B | ||
| +0.63% | +0.12% | +17.07% | +20.50% | 49.15B | ||
| +0.38% | +3.92% | -13.68% | -15.94% | 49.74B | ||
| +1.33% | +2.74% | +25.85% | +55.80% | 48.38B | ||
| -2.28% | +4.50% | +2.63% | +39.28% | 48.84B | ||
| +2.39% | +0.58% | +31.63% | +71.85% | 42.17B | ||
| Average | +0.13% | +2.26% | +4.39% | +40.28% | 85.79B | |
| Weighted average by Cap. | +0.50% | +1.52% | +8.40% | +30.45% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4.16B 414M 372M 347M 315M 591M 39.36B 594M 1.63B 20.43B 1.55B 1.52B 65.71B | 4.84B 481M 432M 403M 365M 686M 45.74B 690M 1.89B 23.74B 1.8B 1.77B 76.35B |
| Net income | 746M 74.09M 66.61M 62.16M 56.34M 106M 7.05B 106M 291M 3.66B 278M 272M 11.77B | 919M 91.3M 82.08M 76.6M 69.43M 130M 8.69B 131M 359M 4.51B 343M 335M 14.5B |
| Net Debt | -1.66B -165M -148M -138M -125M -236M -15.7B -237M -649M -8.15B -619M -606M -26.2B | -2.11B -210M -189M -176M -160M -300M -19.96B -301M -825M -10.36B -788M -771M -33.33B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/10/26 | SEK 307.60 | -0.65% | 146,037 |
| 13/10/26 | SEK 309.60 | -1.34% | 130,361 |
| 12/10/26 | SEK 313.80 | +1.16% | 134,508 |
| 09/10/26 | SEK 310.20 | +3.75% | 149,912 |
| 08/10/26 | SEK 299.00 | +2.33% | 114,795 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SECT B Stock
Select your edition
All financial news and data tailored to specific country editions

















